Event

Namita Sood

MD
Mc Govern Medical School;McGovern Medical School;University of Texas Health Science Center of Houston

Vallerie V. McLaughlin

MD
Director of Pulmonary Hypertension Program, University of Michigan;University of Michigan;University of Michigan Medical Center

Stewart A. Turner

PhD
Arena Pharmaceuticals

Ed L. Parsley

DO
Arena Pharmaceuticals

Preston Klassen

MD
Arena Pharmaceuticals

Jean L. Vachiery

MD
Hôpital Erasme, Cliniques Universitaires De Bruxelles

Ronald J. Oudiz

MD
Harbor UCLA Med Ctr;Harbor-UCLA Medical Center

Ioana R. Preston

MD
Tufts Med Center;Tufts Medical Center

Victor F. Tapson

MD
Cedars Sinai;Cedars-Sinai;Cedars-Sinai Medical Center

Harrison W. Farber

MD
Boston Univ Sch of Med;Boston University School of Medicine;Pulmonary Center, Boston University School of Medicine

Ralinepag Plasma Levels Correlate with Improvements in Functional and Hemodynamic Parameters in Patients with Pulmonary Arterial Hypertension (PAH)